reviewTop 1% cited
Non-alcoholic fatty liver disease and dyslipidemia: An update
Metabolism · 2016 · Vol. 65(8) · pp. 1109–1123
Niki Katsiki(Aristotle University of Thessaloniki)Dimitri P. Mikhailidis✉(University College London)Christos S. Mantzoros(Beth Israel Deaconess Medical Center)
Liver Disease Diagnosis and TreatmentLipid metabolism and disordersDiet, Metabolism, and DiseaseSteatohepatitisDyslipidemiaMedicineFatty liverInternal medicineCirrhosisGastroenterologySteatosisInsulin resistanceMetabolic syndrome
MeSH terms
HumansInsulin ResistanceLiverOxidative StressDisease ProgressionDyslipidemiasNon-alcoholic Fatty Liver Disease
Citations
565
FWCI
29.80
field-weighted impact
References
310
Percentile
100%
vs. same field & year
Citations per year
Cited by
Obesity and cardiovascular disease: revisiting an old relationship
Metabolism · 2018 · 698 citations
References
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
Journal of the American College of Cardiology · 2010 · 4,016 citations
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Hepatology · 2012 · 3,804 citations
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
European Heart Journal · 2011 · 3,538 citations
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
Gastroenterology · 2015 · 2,337 citations
Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
JAMA · 1993 · 27,890 citations
Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease
World Journal of Gastroenterology · 2007 · 536 citations
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
Diabetologia · 2012 · 664 citations
Non-alcoholic fatty liver disease and obesity: Biochemical, metabolic and clinical presentations
World Journal of Gastroenterology · 2014 · 580 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.